Actively Recruiting
Increasing Oral Medication Adherence for Metastatic Breast Cancer Patients
Led by European Institute of Oncology · Updated on 2024-12-20
104
Participants Needed
1
Research Sites
61 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Aim of this study is to optimize an adherence increasing intervention designed for metastatic Breast Cancer (BC) patients by applying a full factorial design in order to evaluate the optimal combination of three different intervention components.
CONDITIONS
Official Title
Increasing Oral Medication Adherence for Metastatic Breast Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with a diagnosis of metastatic BC
- Patients with a prescription for any oral anticancer agent (oral chemotherapy, endocrine therapy, or Cyclin-Dependent Kinase 4/6 Inhibitors)
- Age over 18 years old
- Personal smartphone with internet access
- Willingness and ability to comply with scheduled visits and trial procedures
- Understanding and speaking Italian
- Written informed consent
You will not qualify if you...
- Psychiatric disorders or conditions impairing the ability to give informed consent
- Comorbidities that may affect compliance with study procedures
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
European Institute of Oncology
Milan, Italy, 20141
Actively Recruiting
Research Team
G
Gabriella Pravettoni, MD
CONTACT
M
Mara Negri
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
8
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here